We use cookies for a better user experience. Read our Privacy Policy

I Agree

Animal Drug Compounding Market

Animal Drug Compounding Market (Product: Anti-infectives, Anti-inflammatory, CNS Agents, GI Drugs, and Others; and Route of Administration: Oral, Injectable, Topical, Rectal, and Ocular) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Animal Drug Compounding Market Outlook 2031

  • The global animal drug compounding market was valued at US$ 1.1 Bn in 2021
  • The global market is projected to grow at a CAGR of 7.4% between 2022 and 2031
  • The global animal drug compounding market is anticipated to be reach more than US$ 2.4 Bn by the end of 2031

Analysts’ Viewpoint on Animal Drug Compounding Market Scenario

Animal medicine compounding stakeholders have benefited significantly owing to rapid advancements in production techniques and growth in the pharmaceutical & biotechnology industry. People have become more conscious of the importance of improving animal health, which has increased the demand for veterinary medicine compounding. Officially approved drugs are not always available; hence, compounded medication is a better option for treating a wide range of illnesses. Chewable tablets, for example, are commercially approved products in specific dosage forms and are recommended for usage in specific animal species. The animal drug compounding market has matured due to the increase in owner approval of the practice in the past few years. Key players operating in the market are focusing on partnerships and collaborations to expand their global footprint.

Animal Drug Compounding Market

Animal Drug Compounding Market Introduction

Animal drug compounding is the method of combining, blending, or modifying ingredients to produce a medicine tailored to the needs of a single or small group of animals. These drugs can be used in veterinary medicine. These drugs are typically prepared by pharmacists or veterinarians. Compounded animal drug companies are working harder to maintain a steady supply of chemical compounds and materials to support veterinary compounding. Letco Medical, a provider of pharmaceutical ingredients, is now able to support a formula database that assists in choosing the ideal combination for any animal. Suppliers of APIs, bases, flavors, and formula for veterinary compounding collaborate closely with businesses that produce animal drugs.

Request a sample to get extensive insights into the Animal Drug Compounding Market

Rise in Number of Licensed Veterinarians and Pharmacists Driving Animal Drug Compounding Market Growth

Increase in number of people who own pets has led to the growth of the pharmacy practice of veterinary pharmacists who compound medications or assist pharmacists in producing compounded pet medications. Compounded medications are used to avoid allergens found in animals such as lactose, gluten, dyes, preservatives, and sugars. A veterinarian with knowledge of compounded medications could help in cases where discontinued medications are urgently needed. Governments of several countries are funding programs, fellowships, and grants to help pharmacists develop the necessary skills for medication compounding. For instance, Brazil has 7,211 compounding pharmacies and 16,000 compounding pharmacists.

The EAHP encourages health authorities in Europe to facilitate the transfer of drug store preparations among hospitals and invest in compounding services, as only healthcare facilities are able to respond to patients’ needs and extraordinary situations such as shortage of essential medicines. This is expected to create new opportunities in the market in the next few years.

Increase in Demand for Companion Animals Fueling Global Animal Drug Compounding Market

The global companion animal population has increased in the past few years. The American Veterinary Medical Association (2017-2018 - U.S. Pet Ownership & Demographics Sourcebook) reported that 38.4% of households have dogs and 25.4% have cats. According to FEDIAF, 85 million households in the country own at least one pet animal, with pet-related services and products totaling EUR 19.7 Bn. Similarly, demand for companion animals is high in Brazil, India, China, and Singapore.

Rise in demand for exotic companion animals is driving the need for compounded medication in order to meet their personalized medical care needs. Animals cannot always be treated with the same medications as humans. Compounded medications are used for specific animals, as these can be tailored to the needs of each individual animal. Making medications more palatable by adding flavors and colors is a service that is especially beneficial for pets. Farmers and ranchers use medicines to ensure the health of their livestock, protect public health, and safeguard the food supply.

Request a custom report on Animal Drug Compounding Market

Treatment of Minor as well as Serious Infectious Diseases Bolstering Anti-infectives Segment

In terms of product, the anti-infectives segment is expected to grow at a rapid pace during the forecast period. Anti-infectives, which include antibacterial, antiviral, antifungal, and antiphrastic medications, work to prevent or treat infections. These drugs treat minor infections, and in most cases, cure serious infectious diseases such as pneumonia or tuberculosis. Routine procedures and complex surgeries pose a serious infection risk. Compounding allows to prescribe accurate doses when treating animal patients in need. This is anticipated to propel the anti-infectives segment during the forecast period.

Surge in Number of Companion Animals Across Globe

Based on animal type, the companion animal segment dominated the global market in 2021. Dogs and cats are highly common companion animals. More than 60% of households have cats or dogs as companion animals. As per market trends, market players are striving to diversify their product portfolio through R&D, product launches, and other strategic initiatives. For instance, IDEXX Laboratories, a pet healthcare, veterinary diagnostics, and veterinary practice software company, provides a diverse range of tests, devices, and services for companion animal specialty drugs.

Better Chemical Stability and Faster Dissolution Fueling Powders Segment

In terms of dosage form, the powders segment dominated the global market in 2021. Powders have better chemical stability than liquids and dissolve faster than tablets or capsules. This is a key factor driving the segment. Powder dosage forms have greater physicochemical stability and longer shelf life than liquid dosage forms. Oral powders containing water-soluble drugs dissolve faster than tablets or capsules, which require the disintegration of the tablet or capsule shell prior to dissolution.

High Adoption Rate of Oral Route of Administration

Based on route of administration, the oral segment is projected to dominate the global market in 2021. The oral route of administration is commonly used for companion and food animals. Tablets, capsules, solutions, and suspensions are common oral medications for dogs and cats; pastes are also applied to cats' forelimbs, where they are licked and consumed.

Regional Outlook of Animal Drug Compounding Market

North America accounted for around 40.0% share of the global market in 2021. Well-established healthcare infrastructure and rapid adoption of newer therapeutic strategies are expected to propel the market in the region in the near future. The U.S. is anticipated to account for major share of the market in North America due to presence of large chain pharmacies. The U.S. market is anticipated to be driven by technological advancements in highly efficient, precise, and automatic integrated compounding machines during the forecast period. Rise in cost of drugs and preference for customized drug preparation are expected to propel the market in North America in the near future.

The animal drug compounding market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Rise in acceptance of compounded veterinary planning and preparation is the key factor that is anticipated to increase the market size for animal drug compounding in the region. Moreover, surge in pet ownership is likely to drive the market size in Asia Pacific during the forecast period.

Analysis of Key Players in Global Animal Drug Compounding Market

The global market is consolidated, with the presence of a small number of dominant players. Strategic alliances are being formed by key players in order to increase revenue and market share. Product line expansion and acquisitions & mergers are the other strategies used by players to expand their business footprint. Prominent players operating in the global animal drug compounding market are Custom Med Compounding Pharmacy, Triangle Compounding Pharmacy, Wellness Pharmacy of Cary, Wedgewood Pharmacy, Central Compounding Center South, Millers Pharmacy, Davis Islands Pharmacy, Smith's Pharmacy, Caringbah Compounding Pharmacy, Specialist Compounding Pharmacy Pte Ltd., and Tache Pharmacy.

Key Developments in Animal Drug Compounding Market

  • In March 2021, Osceola Capital and seasoned businessman Jacob Beckel announced the formation of Revelation Pharma Corp to investigate investments and strategic partnerships in the pharmacy compounding market
  • In December 2020, Wedgewood Pharmacy and Partners Group agreed to replace New Harbor Capital as the majority shareholder

Key players have been profiled in the market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Animal Drug Compounding Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 1.1 Bn

Market Forecast Value in 2031

More than US$ 2.4 Bn

Growth Rate

(CAGR) for 2022-2031

7.4%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis.

Competition Landscape

  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Anti-infectives
      • Metranidazole
      • Ketaconazole
      • Others
    • Anti-inflammatory
      • Prednisolone
      • Tramadol
      • Others
    • CNS Agents
      • Potassium Bromide
      • Gabapentin
      • Other CNS Agents
    • GI Drugs
      • Apomorphine
      • Ursodiol
      • Cisapride
      • Other GI Drugs
    • Others
      • Methimazole
      • Others
  • Animal Type
    • Companion Animal
      • Dogs
      • Cats
      • Others
    • Livestock
  • Dosage Form
    • Capsules
    • Solutions
    • Powders
    • Suspension
    • Others
  • Route of Administration
    • Oral
    • Injectable
    • Topical
    • Rectal
    • Ocular
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Wedgewood Pharmacy
  • Triangle Compounding Pharmacy
  • Davis Islands Pharmacy
  • Custom Med Compounding Pharmacy
  • Central Compounding Center South
  • Wellness Pharmacy of Cary
  • Caringbah Compounding Pharmacy
  • Millers Pharmacy, Smith's Pharmacy
  • Specialist Compounding Pharmacy Pte Ltd.
  • Tache Pharmacy

Customization Scope

Available upon request

Pricing

Available upon request

Animal Drug Compounding Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global animal drug compounding market in 2021?

The global animal drug compounding market was valued at US$ 1.1 Bn in 2021

How big will be the global animal drug compounding market in 2031?

The global animal drug compounding market is projected to reach more than US$ 2.4 Bn by 2031

What will be the CAGR of the global animal drug compounding market during the forecast period (2022–2031)?

The global animal drug compounding market is anticipated to grow at a CAGR of 7.4% from 2022 to 2031.

Which are the prominent trends that affect market growth?

Increase in demand for companion animals and focus of manufacturers on drug dose adjustment & taste altering

What is the share of the leading segment of the global animal drug compounding market?

The CNS agents product segment held more than 40.0% share of the global market in 2021

Who are the prominent players in the global Animal drug compounding market?

Wedgewood Pharmacy, Triangle Compounding Pharmacy, Davis Islands Pharmacy, Custom Med Compounding Pharmacy, Central Compounding Center South, Wellness Pharmacy of Cary, Caringbah Compounding Pharmacy, Millers Pharmacy, Smith's Pharmacy, Specialist Compounding Pharmacy Pte Ltd., and Tache Pharmacy

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Animal Drug Compounding Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Animal Drug Compounding Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Technological Advancements

    5.2. Regulatory Scenario by Region/globally

    5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Animal Drug Compounding Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Anti-invectives

            6.3.1.1. Metranidazole

            6.3.1.2. Ketaconazole

            6.3.1.3. Other Anti invectives

        6.3.2. Anti-inflammatory

            6.3.2.1. Prednisolone

            6.3.2.2. Tramadol

            6.3.2.3. Others

        6.3.3. CNS Agents

            6.3.3.1. Potassium bromide

            6.3.3.2. Gabapentin

            6.3.3.3. Other CNS agents

        6.3.4. GI Drugs

            6.3.4.1. Apomorphine

            6.3.4.2. Ursodiol

            6.3.4.3. Cisapride

            6.3.4.4. Other GI Drugs

        6.3.5. Others

    6.4. Market Attractiveness Analysis, by Product

7. Global Animal Drug Compounding Market Analysis and Forecast, by Animal Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Animal Type, 2017–2031

        7.3.1. Companion Animal

            7.3.1.1. Dogs

            7.3.1.2. Cats

            7.3.1.3. Others

        7.3.2. Live Stock

    7.4. Market Attractiveness Analysis, by Animal Type

8. Global Animal Drug Compounding Market Analysis and Forecast, by Dosage Form

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Dosage Form, 2017–2031

        8.3.1. Capsules

        8.3.2. Solutions

        8.3.3. Powders

        8.3.4. Suspension

        8.3.5. Others

    8.4. Market Attractiveness Analysis, by Dosage Form

9. Global Animal Drug Compounding Market Analysis and Forecast, by Route of Administration

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by Route of Administration, 2017–2031

        9.3.1. Oral

        9.3.2. Injectable

        9.3.3. Topical

        9.3.4. Rectal

        9.3.5. Ocular

    9.4. Market Attractiveness Analysis, by Route of Administration

10. Global Animal Drug Compounding Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Region

11. North America Animal Drug Compounding Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Anti-infectives

            11.2.1.1. Metranidazole

            11.2.1.2. Ketaconazole

            11.2.1.3. Other Anti-infectives

        11.2.2. Anti-inflammatory

            11.2.2.1. Prednisolone

            11.2.2.2. Tramadol

            11.2.2.3. Others

        11.2.3. CNS Agents

            11.2.3.1. Potassium bromide

            11.2.3.2. Gabapentin

            11.2.3.3. Other CNS agents

        11.2.4. GI Drugs

            11.2.4.1. Apomorphine

            11.2.4.2. Ursodiol

            11.2.4.3. Cisapride

            11.2.4.4. Other GI Drugs

        11.2.5. Others

    11.3. Market Value Forecast, by Animal Type, 2017–2031

        11.3.1. Companion Animal

            11.3.1.1. Dogs

            11.3.1.2. Cats

            11.3.1.3. Others

        11.3.2. Live Stock

    11.4. Market Value Forecast, by Dosage Form, 2017–2031

        11.4.1. Capsules

        11.4.2. Solutions

        11.4.3. Powders

        11.4.4. Suspension

        11.4.5. Others

    11.5. Market Value Forecast, by Route of Administration, 2017–2031

        11.5.1. Oral

        11.5.2. Injectable

        11.5.3. Topical

        11.5.4. Rectal

        11.5.5. Ocular

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Product

        11.7.2. By Animal Type

        11.7.3. By Dosage Form

        11.7.4. By Route of Administration

        11.7.5. By Country

12. Europe Animal Drug Compounding Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Anti-infectives

            12.2.1.1. Metranidazole

            12.2.1.2. Ketaconazole

            12.2.1.3. Other Anti-infectives

        12.2.2. Anti-inflammatory

            12.2.2.1. Prednisolone

            12.2.2.2. Tramadol

            12.2.2.3. Others

        12.2.3. CNS Agents

            12.2.3.1. Potassium bromide

            12.2.3.2. Gabapentin

            12.2.3.3. Other CNS agents

        12.2.4. GI Drugs

            12.2.4.1. Apomorphine

            12.2.4.2. Ursodiol

            12.2.4.3. Cisapride

            12.2.4.4. Other GI Drugs

        12.2.5. Others

    12.3. Market Value Forecast, by Animal Type, 2017–2031

        12.3.1. Companion Animal

            12.3.1.1. Dogs

            12.3.1.2. Cats

            12.3.1.3. Others

        12.3.2. Live Stock

    12.4. Market Value Forecast, by Dosage Form, 2017–2031

        12.4.1. Capsules

        12.4.2. Solutions

        12.4.3. Powders

        12.4.4. Suspension

        12.4.5. Others

    12.5. Market Value Forecast, by Route of Administration, 2017–2031

        12.5.1. Oral

        12.5.2. Injectable

        12.5.3. Topical

        12.5.4. Rectal

        12.5.5. Ocular

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Product

        12.7.2. By Animal Type

        12.7.3. By Dosage Form

        12.7.4. By Route of Administration

        12.7.5. By Country/Sub-region

13. Asia Pacific Animal Drug Compounding Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Anti-infectives

            13.2.1.1. Metranidazole

            13.2.1.2. Ketaconazole

            13.2.1.3. Other Anti-infectives

        13.2.2. Anti-inflammatory

            13.2.2.1. Prednisolone

            13.2.2.2. Tramadol

            13.2.2.3. Others

        13.2.3. CNS Agents

            13.2.3.1. Potassium bromide

            13.2.3.2. Gabapentin

            13.2.3.3. Other CNS agents

        13.2.4. GI Drugs

            13.2.4.1. Apomorphine

            13.2.4.2. Ursodiol

            13.2.4.3. Cisapride

            13.2.4.4. Other GI Drugs

        13.2.5. Others

    13.3. Market Value Forecast, by Animal Type, 2017–2031

        13.3.1. Companion Animal

            13.3.1.1. Dogs

            13.3.1.2. Cats

            13.3.1.3. Others

        13.3.2. Live Stock

    13.4. Market Value Forecast, by Dosage Form, 2017–2031

        13.4.1. Capsules

        13.4.2. Solutions

        13.4.3. Powders

        13.4.4. Suspension

        13.4.5. Others

    13.5. Market Value Forecast, by Route of Administration, 2017–2031

        13.5.1. Oral

        13.5.2. Injectable

        13.5.3. Topical

        13.5.4. Rectal

        13.5.5. Ocular

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Product

        13.7.2. By Animal Type

        13.7.3. By Dosage Form

        13.7.4. By Route of Administration

        13.7.5. By Country/Sub-region

14. Latin America Animal Drug Compounding Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2017–2031

        14.2.1. Anti-infectives

            14.2.1.1. Metranidazole

            14.2.1.2. Ketaconazole

            14.2.1.3. Other Anti-infectives

        14.2.2. Anti-inflammatory

            14.2.2.1. Prednisolone

            14.2.2.2. Tramadol

            14.2.2.3. Other Anti-inflammatory

        14.2.3. CNS Agents

            14.2.3.1. Potassium bromide

            14.2.3.2. Gabapentin

            14.2.3.3. Other CNS agents

        14.2.4. GI Drugs

            14.2.4.1. Apomorphine

            14.2.4.2. Ursodiol

            14.2.4.3. Cisapride

            14.2.4.4. Other GI Drugs

        14.2.5. Others

    14.3. Market Value Forecast, by Animal Type, 2017–2031

        14.3.1. Companion Animal

            14.3.1.1. Dogs

            14.3.1.2. Cats

            14.3.1.3. Others

        14.3.2. Live Stock

    14.4. Market Value Forecast, by Dosage Form, 2017–2031

        14.4.1. Capsules

        14.4.2. Solutions

        14.4.3. Powders

        14.4.4. Suspension

        14.4.5. Others

    14.5. Market Value Forecast, by Route of Administration, 2017–2031

        14.5.1. Oral

        14.5.2. Injectable

        14.5.3. Topical

        14.5.4. Rectal

        14.5.5. Ocular

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Product

        14.7.2. By Animal Type

        14.7.3. By Dosage Form

        14.7.4. By Route of Administration

        14.7.5. By Country/Sub-region

15. Middle East & Africa Animal Drug Compounding Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Product, 2017–2031

        15.2.1. Anti-infectives

            15.2.1.1. Metranidazole

            15.2.1.2. Ketaconazole

            15.2.1.3. Other Anti-infectives

        15.2.2. Anti-inflammatory

            15.2.2.1. Prednisolone

            15.2.2.2. Tramadol

            15.2.2.3. Other Anti-inflammatory

        15.2.3. CNS Agents

            15.2.3.1. Potassium bromide

            15.2.3.2. Gabapentin

            15.2.3.3. Other CNS agents

        15.2.4. GI Drugs

            15.2.4.1. Apomorphine

            15.2.4.2. Ursodiol

            15.2.4.3. Cisapride

            15.2.4.4. Other GI Drugs

        15.2.5. Others

    15.3. Market Value Forecast, by Animal Type, 2017–2031

        15.3.1. Companion Animal

            15.3.1.1. Dogs

            15.3.1.2. Cats

            15.3.1.3. Others

        15.3.2. Live Stock

    15.4. Market Value Forecast, by Dosage Form, 2017–2031

        15.4.1. Capsules

        15.4.2. Solutions

        15.4.3. Powders

        15.4.4. Suspension

        15.4.5. Others

    15.5. Market Value Forecast, by Route of Administration, 2017–2031

        15.5.1. Oral

        15.5.2. Injectable

        15.5.3. Topical

        15.5.4. Rectal

        15.5.5. Ocular

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Country

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Product

        15.7.2. By Animal Type

        15.7.3. By Dosage Form

        15.7.4. By Route of Administration

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by tier and size of companies)

    16.2. Market Share Analysis, by Company, 2021

    16.3. Company Profiles

        16.3.1. Wedgewood Pharmacy

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Company Financials

            16.3.1.3. Growth Strategies

            16.3.1.4. SWOT Analysis

        16.3.2. Triangle Compounding Pharmacy

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Company Financials

            16.3.2.3. Growth Strategies

            16.3.2.4. SWOT Analysis

        16.3.3. Davis Islands Pharmacy

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Company Financials

            16.3.3.3. Growth Strategies

            16.3.3.4. SWOT Analysis

        16.3.4. Custom Med Compounding Pharmacy

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Company Financials

            16.3.4.3. Growth Strategies

            16.3.4.4. SWOT Analysis

        16.3.5. Central Compounding Center South

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Company Financials

            16.3.5.3. Growth Strategies

            16.3.5.4. SWOT Analysis

        16.3.6. Wellness Pharmacy of Cary

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Company Financials

            16.3.6.3. Growth Strategies

            16.3.6.4. SWOT Analysis

        16.3.7. Caringbah Compounding Pharmacy

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Company Financials

            16.3.7.3. Growth Strategies

            16.3.7.4. SWOT Analysis

        16.3.8. Millers Pharmacy

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Company Financials

            16.3.8.3. Growth Strategies

            16.3.8.4. SWOT Analysis

        16.3.9. Smith's Pharmacy

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Company Financials

            16.3.9.3. Growth Strategies

            16.3.9.4. SWOT Analysis

        16.3.10. Specialist Compounding Pharmacy Pte Ltd.

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Company Financials

            16.3.10.3. Growth Strategies

            16.3.10.4. SWOT Analysis

        16.3.11. Tache Pharmacy

            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.11.2. Company Financials

            16.3.11.3. Growth Strategies

            16.3.11.4. SWOT Analysis

List of Tables

Table 01: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017–2031

Table 03: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017–2031

Table 04: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017–2031

Table 05: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017–2031

Table 06: Global Animal Drug Compounding Market Value (US$ My) Forecast, by Others, 2017–2031

Table 07: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 08: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017–2031

Table 09: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 10: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 11: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Region, 2017–2031 

Table 12: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 13: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 14: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017–2031

Table 15: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017–2031

Table 16: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017–2031

Table 17: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017–2031

Table 18: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017–2031

Table 19: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 20: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017–2031

Table 21: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 22: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 23: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 24: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 25: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017–2031

Table 26: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017–2031

Table 27: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017–2031

Table 28: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017–2031

Table 29: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017–2031

Table 30: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 31: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017–2031

Table 32: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 33: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 34: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 35: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 36: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017–2031

Table 37: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017–2031

Table 38: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017–2031

Table 39: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017–2031

Table 40: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017–2031

Table 41: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 42: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017–2031

Table 43: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 44: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 45: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 46: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 47: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017–2031

Table 48: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017–2031

Table 49: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017–2031

Table 50: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017–2031

Table 51: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017–2031

Table 52: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 53: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017–2031

Table 54: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 55: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 56: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 57: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 58: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017–2031

Table 59: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017–2031

Table 60: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017–2031

Table 61: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017–2031

Table 62: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017–2031

Table 63: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 64: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017–2031

Table 65: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 66: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

List of Figures

Figure 01: Global Animal Drug Compounding Market, by Product, 2021 and 2031

Figure 02: Global Animal Drug Compounding Market Attractiveness Analysis, Product, 2022–2031

Figure 03: Global Animal Drug Compounding Market (US$ Mn), by Anti-infectives, 2017–2031

Figure 04: Global Animal Drug Compounding Market (US$ Mn), by Anti-inflammatory, 2017–2031

Figure 05: Global Animal Drug Compounding Market (US$ Mn), by CNS Agents, 2017–2031

Figure 06: Global Animal Drug Compounding Market (US$ Mn), by GI Drugs, 2017–2031

Figure 07: Global Animal Drug Compounding Market (US$ Mn), by Others, 2017–2031

Figure 08: Global Animal Drug Compounding Market, by Animal Type, 2021 and 2031

Figure 09: Global Animal Drug Compounding Market Attractiveness Analysis, Animal Type, 2022–2031

Figure 10: Global Animal Drug Compounding Market (US$ Mn), by Companion Animal, 2017–2031

Figure 11: Global Animal Drug Compounding Market (US$ Mn), by Livestock Animal, 2017–2031

Figure 12: Global Animal Drug Compounding Market, by Dosage Form, 2021 and 2031

Figure 13: Global Animal Drug Compounding Market Attractiveness Analysis, Dosage Form, 2022–2031

Figure 14: Global Animal Drug Compounding Market (US$ Mn), by Capsules, 2017–2031

Figure 15: Global Animal Drug Compounding Market (US$ Mn), by Solutions, 2017–2031

Figure 16: Global Animal Drug Compounding Market (US$ Mn), by Powders, 2017–2031

Figure 17: Global Animal Drug Compounding Market (US$ Mn), by Suspension, 2017–2031

Figure 18: Global Animal Drug Compounding Market (US$ Mn), by Others, 2017–2031

Figure 19: Global Animal Drug Compounding Market, by Route of Administration, 2021 and 2031

Figure 20: Global Animal Drug Compounding Market Attractiveness Analysis, Route of Administration, 2022–2031

Figure 21: Global Animal Drug Compounding Market (US$ Mn), by Oral, 2017–2031

Figure 22: Global Animal Drug Compounding Market (US$ Mn), by Injectable, 2017–2031

Figure 23: Global Animal Drug Compounding Market (US$ Mn), by Topical, 2017–2031

Figure 24: Global Animal Drug Compounding Market (US$ Mn), by Rectal, 2017–2031

Figure 25: Global Animal Drug Compounding Market (US$ Mn), by Ocular, 2017–2031

Figure 26: Global Animal Drug Compounding Market Value Share Analysis, by Region, 2021 and 2031

Figure 27: Global Animal Drug Compounding Market Attractiveness Analysis, by Region, 2022–2031

Figure 28: North America Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 29: North America Animal Drug Compounding Market Value Share Analysis, by Country, 2021 and 2031

Figure 30: North America Animal Drug Compounding Market Attractiveness Analysis, by Country, 2022–2031

Figure 31: North America Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031

Figure 32: North America Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022–2031

Figure 33: North America Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031

Figure 34: North America Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022–2031

Figure 35: North America Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031

Figure 36: North America Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022–2031

Figure 37: North America Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031

Figure 38: North America Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022–2031

Figure 39: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 40: Europe Animal Drug Compounding Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 41: Europe Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 42: Europe Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031

Figure 43: Europe Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022–2031

Figure 44: Europe Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031

Figure 45: Europe Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022–2031

Figure 46: Europe Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031

Figure 47: Europe Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022–2031

Figure 48: Europe Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031

Figure 49: Europe Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022–2031

Figure 50: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 51: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 52: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 53: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031

Figure 54: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022–2031

Figure 55: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031

Figure 56: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022–2031

Figure 57: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031

Figure 58: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022–2031

Figure 59: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031

Figure 60: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022–2031

Figure 61: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 62: Latin America Animal Drug Compounding Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 63: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 64: Latin America Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031

Figure 65: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022–2031

Figure 66: Latin America Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031

Figure 67: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022–2031

Figure 68: Latin America Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031

Figure 69: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022–2031

Figure 70: Latin America Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031

Figure 71: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022–2031

Figure 72: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 73: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 74: Middle East and Africa Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 75: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031

Figure 76: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022–2031

Figure 77: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031

Figure 78: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022–2031

Figure 79: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031

Figure 80: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022–2031

Figure 81: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031

Figure 82: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

704

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved